Background <p>Hereditary forms of obesity are characterized by early severe heterogeneous manifestations of the phenotype along with a rapid progression to morbid obesity, primary due to pathogenic variants of certain genes. Most forms are characterized by moderate to severe neuropsychic developmental delays, dysmorphic features and organ-specific developmental anomalies.</p> Result <p>We searched for hereditary causes of morbid obesity in children by exome sequencing. As a result, we have identified 5 variants in the <i>GNAS</i> locus, two of which were identified for the first time: NM_000516.7(<i>GNAS</i>):c.201del, (p.Phe68Leufs*32) and NM_000516.7(<i>GNAS</i>):c.586 − 18_591del. Children showed tolerance to parathyroid hormone and thyroid-stimulating hormone. It has been observed that almost all the children with frameshift variants or nonsense mutations presented with subcutaneous ossifications.</p> Conclusions <p>The search for variants in a group of patients with morbid obesity, as conducted in our research, reaffirms the need for use molecular genetic testing to determine the main diagnosis and facilitate early detection of the disease. This is particularly relevant given the wide clinical variability of monogenic forms of obesity.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Significance of GNAS mutations for morbid obesity in children

  • Ramil R. Salakhov,
  • Rita I. Khusainova,
  • Olga V. Vasyukova,
  • Daria A. Kopytina,
  • Bulat I. Yalaev,
  • Yulia S. Karpova,
  • Pavel L. Okorokov,
  • Valentina A. Peterkova,
  • Ildar R. Minniakhmetov,
  • Natalia G. Mokrysheva

摘要

Background

Hereditary forms of obesity are characterized by early severe heterogeneous manifestations of the phenotype along with a rapid progression to morbid obesity, primary due to pathogenic variants of certain genes. Most forms are characterized by moderate to severe neuropsychic developmental delays, dysmorphic features and organ-specific developmental anomalies.

Result

We searched for hereditary causes of morbid obesity in children by exome sequencing. As a result, we have identified 5 variants in the GNAS locus, two of which were identified for the first time: NM_000516.7(GNAS):c.201del, (p.Phe68Leufs*32) and NM_000516.7(GNAS):c.586 − 18_591del. Children showed tolerance to parathyroid hormone and thyroid-stimulating hormone. It has been observed that almost all the children with frameshift variants or nonsense mutations presented with subcutaneous ossifications.

Conclusions

The search for variants in a group of patients with morbid obesity, as conducted in our research, reaffirms the need for use molecular genetic testing to determine the main diagnosis and facilitate early detection of the disease. This is particularly relevant given the wide clinical variability of monogenic forms of obesity.